Evolution of myeloid-mediated immunotherapy resistance in prostate cancerAram Lyu, Lawrence Fong, Zenghua Fan et al.|Nature|2024Cited by 138
Abstract 4325: FXYD5 plays diverse roles in immune evasion and tumor progression in prostate cancerRu Wen, James D. Brooks, Gerald E. Marti et al.|Cancer Research|2025Cited by 1
548 Evolution of myeloid-mediated mechanisms of immunotherapy resistance at single-cell resolution with human prostate cancer progressionAram Lyu, Lawrence Fong, Zenghua Fan et al.|Regular and Young Investigator Award Abstracts|2023Cited by 1
Abstract PR003: A feed-forward loop in the adenosine signaling pathway drives myeloid-mediated resistance to immune checkpoint inhibition in prostate cancerAram Lyu, Lawrence Fong, Zenghua Fan et al.|Cancer Immunology Research|2025Cited by 0
463 Dissecting myeloid-driven mechanisms of immunotherapy resistance in prostate cancer bone metastasesAram Lyu, Lawrence Fong, Zenghua Fan et al.|Regular and Young Investigator Award Abstracts|2025Cited by 0